Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study.

Nikiphorou E, de Lusignan S, Mallen CD, Khavandi K, Bedarida G, Buckley CD, Galloway J, Raza K.

Heart. 2020 Mar 24. pii: heartjnl-2019-316193. doi: 10.1136/heartjnl-2019-316193. [Epub ahead of print]

2.

"A Step and a Ceiling": mechanical properties of Ca2+ spark vasoregulation in resistance arteries by pressure-induced oxidative activation of PKG.

Csato V, Kadir SZSA, Khavandi K, Bennett H, Sugden S, Gurney AM, Pritchard HT, Hill-Eubanks D, Eaton P, Nelson MT, Greenstein AS.

Physiol Rep. 2019 Nov;7(22):e14260. doi: 10.14814/phy2.14260.

3.

Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study.

Nikiphorou E, de Lusignan S, Mallen C, Roberts J, Khavandi K, Bedarida G, Buckley CD, Galloway J, Raza K.

Rheumatology (Oxford). 2019 Oct 3. pii: kez409. doi: 10.1093/rheumatology/kez409. [Epub ahead of print]

PMID:
31580449
4.

Haematological abnormalities in new-onset rheumatoid arthritis and risk of common infections: a population-based study.

Nikiphorou E, de Lusignan S, Mallen C, Khavandi K, Roberts J, Buckley CD, Galloway J, Raza K.

Rheumatology (Oxford). 2019 Sep 9. pii: kez344. doi: 10.1093/rheumatology/kez344. [Epub ahead of print]

PMID:
31501866
5.

Abnormal Remodeling of Subcutaneous Small Arteries Is Associated With Early Diastolic Impairment in Metabolic Syndrome.

Khavandi K, Aghamohammadzadeh R, Luckie M, Brownrigg J, Alam U, Khattar R, Malik RA, Heagerty AM, Greenstein AS.

J Am Heart Assoc. 2017 Apr 11;6(4). pii: e004603. doi: 10.1161/JAHA.116.004603.

6.

Pressure-induced oxidative activation of PKG enables vasoregulation by Ca2+ sparks and BK channels.

Khavandi K, Baylie RA, Sugden SA, Ahmed M, Csato V, Eaton P, Hill-Eubanks DC, Bonev AD, Nelson MT, Greenstein AS.

Sci Signal. 2016 Oct 11;9(449):ra100. doi: 10.1126/scisignal.aaf6625.

7.

The ebbs and flows in the development of cholesterol-lowering drugs: prospects for the future.

Hajhosseiny R, Sabir I, Khavandi K, Wierzbicki AS.

Clin Pharmacol Ther. 2014 Jul;96(1):64-73. doi: 10.1038/clpt.2014.76. Epub 2014 Apr 3. Review.

PMID:
24699033
8.

Oral anticoagulants for Asian patients with atrial fibrillation.

Sabir I, Khavandi K, Brownrigg J, Camm AJ.

Nat Rev Cardiol. 2014 May;11(5):290-303. doi: 10.1038/nrcardio.2014.22. Epub 2014 Mar 11. Review. Erratum in: Nat Rev Cardiol. 2014 Dec;11(12):686.

PMID:
24614113
9.

Have we reached the limits for the treatment of diabetic nephropathy?

Hajhosseiny R, Khavandi K, Jivraj N, Mashayekhi S, Goldsmith DJ, Malik RA.

Expert Opin Investig Drugs. 2014 Apr;23(4):511-22. doi: 10.1517/13543784.2014.892580. Epub 2014 Feb 21. Review.

PMID:
24555907
10.

DPP-IV inhibitors: Beyond glycaemic control?

Kwok AJ, Mashar M, Khavandi K, Sabir I.

Trends Cardiovasc Med. 2014 May;24(4):157-64. doi: 10.1016/j.tcm.2013.10.002. Epub 2013 Oct 31. Review.

PMID:
24296298
11.

Strategies for preventing type 2 diabetes: an update for clinicians.

Khavandi K, Amer H, Ibrahim B, Brownrigg J.

Ther Adv Chronic Dis. 2013 Sep;4(5):242-61. doi: 10.1177/2040622313494986.

12.

The prevalence of electrocardiographic early repolarization in an adult cohort with chronic kidney disease and its impact upon all-cause mortality and progression to dialysis.

Hajhosseiny R, Rajani R, Khavandi K, Sebag FA, Mashayekhi S, Wright M, Goldsmith D.

Front Physiol. 2013 May 31;4:127. doi: 10.3389/fphys.2013.00127. eCollection 2013.

13.

Preoperative hematocrit concentration and the risk of stroke in patients undergoing isolated coronary-artery bypass grafting.

Musallam KM, Jamali FR, Rosendaal FR, Richards T, Spahn DR, Khavandi K, Barakat I, Demoss B, Lotta LA, Peyvandi F, Sfeir PM.

Anemia. 2013;2013:206829. doi: 10.1155/2013/206829. Epub 2013 Apr 30.

14.

Retinal arterial hypertrophy: the new LVH?

Khavandi K, Arunakirinathan M, Greenstein AS, Heagerty AM.

Curr Hypertens Rep. 2013 Jun;15(3):244-52. doi: 10.1007/s11906-013-0347-2. Review.

PMID:
23575736
15.

Cardiovascular disease in chronic kidney disease: untying the Gordian knot.

Hajhosseiny R, Khavandi K, Goldsmith DJ.

Int J Clin Pract. 2013 Jan;67(1):14-31. doi: 10.1111/j.1742-1241.2012.02954.x. Epub 2012 Jul 11. Review.

PMID:
22780692
16.

Interrupting the natural history of diabetes mellitus: lifestyle, pharmacological and surgical strategies targeting disease progression.

Khavandi K, Brownrigg J, Hankir M, Sood H, Younis N, Worth J, Greenstein A, Soran H, Wierzbicki A, Goldsmith DJ.

Curr Vasc Pharmacol. 2014 Jan;12(1):155-67. Review.

PMID:
22272898
17.

Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease.

Chrysochou C, Foley RN, Young JF, Khavandi K, Cheung CM, Kalra PA.

Nephrol Dial Transplant. 2012 Apr;27(4):1403-9. doi: 10.1093/ndt/gfr496. Epub 2011 Oct 12.

PMID:
21993376
18.

Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study.

Musallam KM, Tamim HM, Richards T, Spahn DR, Rosendaal FR, Habbal A, Khreiss M, Dahdaleh FS, Khavandi K, Sfeir PM, Soweid A, Hoballah JJ, Taher AT, Jamali FR.

Lancet. 2011 Oct 15;378(9800):1396-407. doi: 10.1016/S0140-6736(11)61381-0. Epub 2011 Oct 5.

PMID:
21982521
19.

The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease.

Kalra PA, Chrysochou C, Green D, Cheung CM, Khavandi K, Sixt S, Rastan A, Zeller T.

Catheter Cardiovasc Interv. 2010 Jan 1;75(1):1-10. doi: 10.1002/ccd.22290.

PMID:
19937777
20.

Diabetic cardiomyopathy--a distinct disease?

Khavandi K, Khavandi A, Asghar O, Greenstein A, Withers S, Heagerty AM, Malik RA.

Best Pract Res Clin Endocrinol Metab. 2009 Jun;23(3):347-60. doi: 10.1016/j.beem.2008.10.016. Review.

PMID:
19520308
21.

Eutrophic remodeling of small arteries in type 1 diabetes mellitus is enabled by metabolic control: a 10-year follow-up study.

Greenstein AS, Price A, Sonoyama K, Paisley A, Khavandi K, Withers S, Shaw L, Paniagua O, Malik RA, Heagerty AM.

Hypertension. 2009 Jul;54(1):134-41. doi: 10.1161/HYPERTENSIONAHA.109.129718. Epub 2009 May 26.

PMID:
19470882
22.

Diabetic cardiomyopathy.

Asghar O, Al-Sunni A, Khavandi K, Khavandi A, Withers S, Greenstein A, Heagerty AM, Malik RA.

Clin Sci (Lond). 2009 May;116(10):741-60. doi: 10.1042/CS20080500. Review.

23.

Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients.

Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM.

Circulation. 2009 Mar 31;119(12):1661-70. doi: 10.1161/CIRCULATIONAHA.108.821181. Epub 2009 Mar 16.

PMID:
19289637
24.

n-3 Polyunsaturated fatty acids are still underappreciated and underused post myocardial infarction.

Khavandi A, Khavandi K, Greenstein A, Karsch K, Heagerty AM.

Heart. 2009 Apr;95(7):540-1. doi: 10.1136/hrt.2008.161430. Epub 2009 Jan 8. No abstract available.

PMID:
19131442
25.

Vascular remodeling: implications for small artery function and target organ damage.

Sonoyama K, Greenstein A, Price A, Khavandi K, Heagerty T.

Ther Adv Cardiovasc Dis. 2007 Dec;1(2):129-37. doi: 10.1177/1753944707086358. Review.

PMID:
19124402
26.

Myogenic tone and small artery remodelling: insight into diabetic nephropathy.

Khavandi K, Greenstein AS, Sonoyama K, Withers S, Price A, Malik RA, Heagerty AM.

Nephrol Dial Transplant. 2009 Feb;24(2):361-9. doi: 10.1093/ndt/gfn583. Epub 2008 Nov 21. Review. No abstract available.

PMID:
19028754
27.

Career choices in 21st-century healthcare: Aiming for a moving target.

Brownrigg JR, Khavandi K, McCollum CN.

Int J Surg. 2008 Dec;6(6):435-6. doi: 10.1016/j.ijsu.2008.08.007. Epub 2008 Sep 3. No abstract available.

Supplemental Content

Loading ...
Support Center